These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18990317)

  • 1. Homocysteine: the Rubik's cube of cardiovascular risk factors.
    Milani RV; Lavie CJ
    Mayo Clin Proc; 2008 Nov; 83(11):1200-2. PubMed ID: 18990317
    [No Abstract]   [Full Text] [Related]  

  • 2. Homocysteine and coronary heart disease.
    Clarke R; Lewington S
    Semin Vasc Med; 2002 Nov; 2(4):391-9. PubMed ID: 16222629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine-lowering trials for prevention of heart disease and stroke.
    Clarke R
    Semin Vasc Med; 2005 May; 5(2):215-22. PubMed ID: 16047274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperhomocysteinemia. A new coronary risk factor].
    Zacarías-Castillo R; Hernández-Rebollar AE; Zajarias-Rabchinskey A; González-Bárcena D
    Gac Med Mex; 2001; 137(4):335-45. PubMed ID: 11519357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma homocysteine level and myocardial infarction: how high is high enough to need intervention?
    Ghosh K
    South Med J; 2006 Aug; 99(8):796-7. PubMed ID: 16929868
    [No Abstract]   [Full Text] [Related]  

  • 6. The controversial role of B-vitamins in cardiovascular risk: An update.
    Ntaios G; Savopoulos C; Grekas D; Hatzitolios A
    Arch Cardiovasc Dis; 2009 Dec; 102(12):847-54. PubMed ID: 19963194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhomocysteinemia: an additional cardiovascular risk factor.
    Fanapour PC; Yug B; Kochar MS
    WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
    Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine and cardiovascular risk in patients with diabetes mellitus.
    Yeromenko Y; Lavie L; Levy Y
    Nutr Metab Cardiovasc Dis; 2001 Apr; 11(2):108-16. PubMed ID: 11434188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Homocysteine--risk factor or risk indicator?].
    Rafflenbeul W
    MMW Fortschr Med; 2005 Nov; 147(44):28-30. PubMed ID: 16302487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine and dementias.
    Loscalzo J
    N Engl J Med; 2002 Feb; 346(7):466-8. PubMed ID: 11844846
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hyperhomocysteinemia as a vascular risk factor in chronic hemodialysis patients].
    Trimarchi H; Young P; Díaz ML; Schropp J; Forrester M; Freixas E
    Medicina (B Aires); 2005; 65(6):513-7. PubMed ID: 16433478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Homocysteine as a coronary risk factor].
    Derbeneva SA; Pogozheva AV
    Vopr Pitan; 2003; 72(5):43-8. PubMed ID: 14619617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factors for cardiovascular diseases: what is the role for homocysteine?].
    Bendini MG; Lanza GA; Mazza A; Giordano A; Leggio M; Menichini G; De Cristofaro R; Moriconi E; Cozzari L; Farina SM; Giordano G
    G Ital Cardiol (Rome); 2007 Mar; 8(3):148-60. PubMed ID: 17461357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine and cholesterol: guilt by association?
    Obeid R; Herrmann W
    Stroke; 2009 Jul; 40(7):e516; author reply e517. PubMed ID: 19461017
    [No Abstract]   [Full Text] [Related]  

  • 17. Does homocysteine promote atherosclerosis?
    Lentz SR
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1385-6. PubMed ID: 11557659
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence suggests diabetes outcomes linked to homocysteine.
    Clement L
    Nephrol News Issues; 2003 Dec; 17(13):16-7. PubMed ID: 14694857
    [No Abstract]   [Full Text] [Related]  

  • 19. [Atherosclerosis as a systemic disease].
    Lahoz C; Mostaza JM
    Rev Esp Cardiol; 2007 Feb; 60(2):184-95. PubMed ID: 17338883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease.
    Schernthaner GH; Plank C; Minar E; Bieglmayer C; Koppensteiner R; Schernthaner G
    Eur J Clin Invest; 2006 May; 36(5):333-9. PubMed ID: 16634837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.